References
Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training: a thematic review. J Gen Int Med. 2005;20:777–86.
Bellin M, McCarthy S, Drevlow L, Pierach C. Medical students’ exposure to pharmaceutical industry marketing: a survey at one U.S. medical school. Acad Med. 2004;79:1041–5.
Chren MM, Landefeld S, Murray T. Doctors, drug companies, and gifts. JAMA. 1989;262:3448–51.
AMSA’s PharmFree Campaign. http://www.amsa.org/prof/pharmfree.cfm (accessed 28 July 2005).
References
Shrank WH, Reed VA, Jernstendt C. Fostering professionalism in medical education: a call for improved assessment and meaningful incentives. J Gen Intern Med. 2004;19:887–92.
Kenny NP, Mann KV, MacLeod H. Role modeling in physicians’ professional formation: reconsidering an essential but untapped educational strategy. Acad Med. 2003;78:1201–2.
Wright SM, Kern DE, Kolodner K, Howard DM, Brancati FL. Attributes of excellent attending-physician role models. N Engl J Med. 1998;339:1986–93.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wen, L.S., McCoy, C., Zipkin, D.A. et al. Response to “interactions between pharmaceutical representatives and doctors in training: A thematic review”. J GEN INTERN MED 21, 103 (2006). https://doi.org/10.1111/j.1525-1497.2005.00271_4.x
Issue Date:
DOI: https://doi.org/10.1111/j.1525-1497.2005.00271_4.x